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agnetic Resonance
oronary Angiography
he Condemned Live Longer*
ike Nagel, MD, PHD
ondon, United Kingdom
agnetic resonance coronary angiography (MRCA) has
een around for several decades (1). Early reports (2)
emonstrated the principal feasibility of the technique to
isualize the coronary arteries and coronary artery stenoses
oninvasively. Major advances were achieved by moving
rom breath-hold imaging to navigator-corrected datasets
3). This allowed measuring during free breathing, achiev-
ng higher spatial resolution and shorter acquisition time per
ardiac cycle. The development of T2 preparation pulses to
uppress the signal from the myocardium and enhance the
ontrast between blood and surrounding tissue (4) led to
uphoric reactions in the community based on excellent
reliminary data and robust image quality. As a conse-
uence, the first multicenter MRCA trial was conducted
5). Even though this was a milestone for cardiovascular
See page 983
agnetic resonance (MR) imaging, being the first inter-
ational multicenter study in the field, it had sobering
esults. Despite interpretable image quality in 84% of the
roximal and middle coronary artery segments, the spec-
ficity only reached 42%. The method at this stage, however,
llowed the exclusion of triple-vessel disease and left main
oronary artery stenosis with a negative predictive value
NPV) of 100%.
The next years were used to improve the signal of the
oronary artery lumen and further suppress the surrounding
issue. Intravascular contrast agents yielded interesting re-
ults with very good image quality in healthy volunteers; the
pplication in patients, however, did not lead to the ex-
ected outcomes (6,7). Similar to other areas of cardiovas-
ular MR imaging, the development of steady-state free
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harma, and consulting fees from Philips Healthcare.recession (SSFP) techniques resulted in a superior signal and
ontrast to noise ratio of the coronary artery lumen against the
yocardium compared with intravascular contrast agents and
s now the established approach for MRCA (8).
The last major step toward diagnostic coronary artery
maging with MR imaging was the development of
-dimensional data acquisition schemes covering the whole
eart (7). This was made possible by the previous step, the
evelopment of SSFP techniques, because these techniques
ield a high T1/T2 signal for blood, which is nearly
ndependent of inflowing signal. Consequently, large
-dimensional volumes, rather than thin 2-dimensional
lices, could be obtained. An advantage of this approach is
he higher signal-to-noise ratio obtained by 3- versus
-dimensional imaging. By adapting the acquisition dura-
ion and time point of data acquisition to the coronary rest
eriod, which is determined individually for each patient,
he influence of cardiac motion on image quality can be
inimized (9).
Again there were euphoric reactions based on excellent
esults in single-center studies, followed by sobering results
hen applied to a broader patient population. MR coronary
rtery imaging was dead—or was it?
evival
he renewed interest in MRCA came from Asia, triggered
y beautiful images, resembling what we are used to from
omputed tomography angiography (CTA). Then, excellent
esults were presented from single centers (10). Should we
ow be euphoric again?
In this issue of the Journal, Kato et al. (11) present their
esults from a 7-center Japanese MRCA trial. They report
n 138 patients imaged with a 3-dimensional, navigator-
orrected SSFP whole-heart MRCA sequence. Of the
RCA studies, 92% were completed; average imaging time
as just 10 min. Sensitivity was 88%, specificity was 72%,
nd positive predictive value (PPV) and NPV were 71% and
8%, respectively. Left main coronary artery stenosis and
riple-vessel disease were excluded with an NPV of 99%.
Kato et al. (11) optimized nearly every step in the
rocedure. They administered nitrates to dilate the coronary
rteries, used an abdominal belt to reduce abdominal
reathing motion, tailored data acquisition to cardiac mo-
ion using patient-specific acquisition windows and time
oints, and applied T2 preparation as well as fat suppression
or better contrast and less venous signal. By stopping data
cquisition after 30 min, they excluded the “bad breathers.”
Using such an optimized approach in an Asian popula-
ion led to results superior to those of the cited previous
ulticenter study (5). When comparing the current results
ith those of recent multicenter computed tomography
tudies (CORE-64 [Diagnostic Accuracy of Multi-
etector Spiral Computed Tomography Angiography Us-
ng 64 Detectors] [12] and ACCURACY [Assessment by
oronary Computed Tomographic Angiography of Indi-
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September 14, 2010:992–4 Magnetic Resonance Coronary Angiographyiduals Undergoing Invasive Coronary Angiography] [13]),
imilarities and differences can be detected (Fig. 1).
umber of patients excluded from the final analysis and
easons for exclusion. The current study population was
reselected by exclusion of patients with pacemakers, atrial
brillation, and previous bypass surgery. Patients with stents
ere included, but the stented segments were not analyzed.
he main reason for not completing the study (8%) was
rift of the diaphragm. In the CORE-64 study, patients
ith an Agatston calcium score of 600 (22% of the total
opulation) were excluded from the analysis (12). Only the
CCURACY trial included all patients (13).
PV. The PPV of CTA is superior to that of MRCA.
ven though considerable progress has been made over the
ast few years, this significantly weakens this technique in
atients with intermediate pre-test probabilities.
PV. The NPV of the 2 MRCA multicenter trials is
dentical to the NPV of the CORE-64 study. All 3
tudies, however, show inferior NPVs compared with the
CCURACY study. Remarkably, however, the value of
RCA in patients with a low pre-test likelihood is
imilar to computed tomography and can reliably rule out
oronary artery disease in patients with a pre-test likeli-
ood of 20%. These patients, who are often younger,
redominantly female, and require 1 scan over their
Figure 1 Predictive Values
Positive predictive value (PPV) (solid lines) and negative predictive value (NPV) (da
for the 2 major magnetic resonance and the 2 major computed tomography multicifetime, would highly benefit from a radiation-free dechnique. In addition, in patients with a relatively high
ikelihood of coronary artery disease, it is important to
ule out triple-vessel disease and left main coronary artery
tenosis (achieved with 99% negative predictive value in
he current study) and significant myocardial ischemia.
erfusion imaging is probably the best study for this, and
ven though most data are available for single-photon
mission computed tomography, MR perfusion seems to
e a valid and nonionizing alternative (14).
tudy Limitations
learly, the study has its limitations, and several steps need
o be taken before a new era of euphoria for MRCA might
egin. 1) Patients were included in only 7 Japanese centers
ver a period of 2 years. A follow-up study with faster
nclusion in more centers distributed around the world
eeds to follow. 2) Patients had a relatively low body mass
ndex (BMI) (average 24  4 kg/m2). Even though no
ignificant differences were observed between patients with
BMI 25 and 25 kg/m2, there was a tendency toward
ess accuracy in patients with a higher BMI. Thus, it will be
nteresting to see how the technique performs in a Western
opulation. 3) The centers expended much effort perform-
ng the study. Most cardiovascular MR studies are not only
lines) for different prevalences
coronary angiography studies.shed
enterirected toward the coronary arteries, but are combined with
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Magnetic Resonance Coronary Angiography September 14, 2010:992–4erfusion imaging and delayed enhancement. This combi-
ation might lead to weaker results, because cardiovascular
R is still a relatively complex technique, and small errors
ead to significant reductions of image quality.
utlook
ost likely, the future of MRCA will not demonstrate a
ajor step change; rather, it will continue to develop slowly.
n the foreseeable future, the utilization of multichannel
oils (e.g., 32 channels), which yield a considerably higher
ignal-to-noise ratio, will lead to further improvement (or at
east cover the loss expected by transferring the technique to
Western population). Similarly, higher field strengths
e.g., 3.0-T) are refined continuously, and even though
reliminary results have not been superior to those with
.5-T magnets (15), continuous improvements are made,
esulting in better pre-pulses and better shimming proce-
ures, and thus fewer artifacts. It has also been shown that
he application of beta-blockers leads to favorable coronary
rtery images with MR. Even though the ultimate goal
hould be to avoid pre-medication, the doses required for
R imaging are well below those for CTA because the
ain effect seems to be the reduction of heart rate variability
ather than the need for very low heart rates (16).
onclusions
ompared with CTA, MRCA is still a cumbersome
ethod with a higher failure rate, longer scan times, and
ess accuracy due to the lower PPV. However, the results of
ato et al. (11) show that MRCA is evolving slowly but
teadily, and we should continue to look out for this
ethod. Clearly, a noninvasive test to determine the signif-
cance of coronary artery stenosis (stress perfusion imaging)
nd visualizing the morphologic correlate (coronary artery
maging) in 1 examination without the use of ionizing
adiation would be highly attractive. In addition, scar tissue,
hich is a strong prognostic parameter in ischemic and
onischemic heart disease, can be detected with excellent
ccuracy.
eprints and correspondence: Dr. Eike Nagel, King’s College
ondon, Imaging Sciences, The Rayne Institute, 4th Floor Lam-
eth Wing, St. Thomas’ Hospital, London SE1 7EH, United
ingdom. E-mail: eike.nagel@kcl.ac.uk. K
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